Traws PharmaTRAW
13F holders, Q3 2024 (September 30)11holders
$5.88avg. 13F price*
At the end of Q3 2024, 11 institutions reported holding Traws Pharma Inc. (TRAW) in their 13F filings. The largest holders were Orbimed Advisors LLC ($3.6M), Vanguard Group Inc. ($157K) and BlackRock, Inc. ($59K).
- Company
- Traws Pharma Inc.
- CUSIP
- 68232V884
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $41 |
| Exits | 0 | $0 |
Ownership 11 holders
| Orbimed Advisors LLC | 0.07% | Add +1348.3% | 605,531 | $3.6M |
| Vanguard Group Inc. | 0.00% | Reduce -5.5% | 26,722 | $157K |
| BlackRock, Inc. | 0.00% | — | 9,956 | $59K |
| Bank of America Corp. | 0.00% | Add +25474.2% | 2,138 | $13K |
| Morgan Stanley | 0.00% | Reduce -0.2% | 729 | $4K |
| UBS Group AG | 0.00% | Reduce -84.0% | 630 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +170.1% | 379 | $2K |
| Vermillion & White Wealth Management Group, LLC | 0.00% | Reduce -0.2% | 205 | $1K |
| Group One Trading LLC | 0.00% | Reduce -0.8% | 64 | $376 |
| Danske Bank A/S | 0.00% | New | 7 | $41 |
| Pacific Capital Wealth Advisors, Inc. | 0.00% | Reduce -24.2% | 2 | $12 |
"% of holder's portfolio" is TRAW's weight in each manager's 13F, not the share of Traws Pharma Inc. the manager owns.